HealthFlex
×
  • Home
  • Conference
    • Why should you attend?
    • Scientific Program
    • Speakers
    • Registration
    • Sponsorship
    • Poster Submission
    • Frequently Asked Questions
    • Media Partners
  • Location & Travel
    • The Venue
    • Flight & Hotel
    • Milan Travel Guide
  • Gallery
  • Sponsors
  • Contact
  • Register
Gregory Fiore

Gregory Fiore

Chief Executive Officer at Exacis Biotherapeutics

Dr. Fiore is a pharmaceutical / biotechnology executive and entrepreneur. He is a co-founder and is the President and CEO of Exacis Biotherapeutics, a development stage immuno-oncology company producing engineered iPSC derived NK cells for treatment of cancer. He is a co-founder and is the former CEO of Sollis Therapeutics, a clinical-stage analgesics therapeutics company. Here Dr. Fiore led fundraising efforts and raised up to $50M to perform a pivotal clinical trial for the company’s lead asset. Before this Dr. Fiore provided senior medical support as consultant and acting CMO for several early-stage biotechnology companies through two successful consultancies he founded, SSI Strategy and Fiore Healthcare Advisors, both of which have been acquired. Dr. Fiore was the first CMO of The Medicines Company (acquired by Novartis) and held leadership roles at Merck and Abbott Laboratories (now Abbvie). Dr. Fiore was a management consultant at McKinsey and Company previously. Dr. Fiore completed Internal Medicine residency and received clinical Pulmonary / Critical Care training at Harvard Medical School following graduation as class valedictorian with an MD degree from New York Medical College.

Dr. Fiore serves on several Medical and Business Advisory Committees / Boards. He is on the Executive Board of the Institute of Neuromodulation, Business Advisory Board for the Advanced Group of Companies, and Editorial Advisory Board of the industry publication Clinical Leader. He serves as an advisor to several biotechnology companies.

__________________

Thu. February 23 | 4.30pm – Panel Discussion

  • Ensuring clinical success: Clinical data generation
  • The future and commercial sustainability of ATMPs
  • ATMP – Regulatory, process and supply chain: Challenges & opportunities
  • CGT Bioprocessing and digitalization
  • Viral-Vector Therapies at scale: today’s Challenges and future opportunities

The BioTech Pharma Summit brings together the movers and shakers in Pharma & Biotech industry from several areas. Uniting niche and top buyers and sellers.

(+351) 915 239 640

client@genapsummit.com

https://biotechpharmasummit.com

Av. da República 676 Office 2, 4430-190 Vila Nova de Gaia

Quick Links

  • GENAP Summit
    • Why should you attend?
    • Registration
    • Scientific Program
    • Speakers
    • Sponsorship
    • Poster Submission
    • Frequently Asked Questions
    • Sponsors
    • Media Partners
  • Location & Travel
    • The Venue
    • Flight & Hotel
  • Gallery
  • Contact GENAP Team

Twitter

BioTech Pharma Summit Follow

biotechsummit
biotechsummit BioTech Pharma Summit @biotechsummit ·
14 Feb

📢We are proud to present Dr. Frank Staal as a keynote speaker for the GENAP Summit 2023 in Milan, Italy
👉Register now at: https://genapsummit.com/
#GENAP23 #atmp #cmc #gct #robotics #hpapi #stemcelltherapy #stemcell #genetherapy

Reply on Twitter 1625484989730111491 Retweet on Twitter 1625484989730111491 Like on Twitter 1625484989730111491 Twitter 1625484989730111491
Terms & Conditions | Privacy Policy

© 2017 Copyright All Rights Reserved | Powered by EPM Group

GENAP Summit is a brand owned by EPM Group, registered company in Portugal. EU VAT ID PT513501312